Products
Telimomab Aritox Biosimilar Antibody-Toxin Conjugate (CD5) for Research
Cat No.: GMP-Bios-INN-1016
Pre-made Telimomab Aritox benchmark antibody (ADC, anti-CD5 therapeutic antibody, Anti-LEU1/T1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Telimomab aritox is a mouse monoclonal antibody which is an immunosuppressive drug. The antibody is linked to the A chain of the ricin protein (which is reflected by the aritox in the drug's name).[1]
Order Information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-1016-1mg | 1mg | |
| GMP-Bios-INN-1016-10mg | 10mg | |
| GMP-Bios-INN-1016-100mg | 100mg | |
| GMP-Bios-INN-1016-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Telimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody |
| INN Name | Telimomab Aritox |
| Target | CD5 |
| Format | ADC |
| Derivation | Mus musculus |
| Species Reactivity | human |
| CH1 Isotype | Fab - nd - nd |
| VD LC | Fab - nd - nd |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | 0 |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | 0 |
